Author:
Kurteva G. P.,Kurtev P. F.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Short Product Characteristic (SPS)/ 20/11/2007
2. http://www.emea.europa.eu/search.php?q=adjuvant+Glivec&site=emea_collection&entqr=0&output=xml_no_dtd&sort=date%3AD%3AL%3Ad1&entsp=0&client=emea_frontend&ud=1&oe=UTF-8&ie=UTF-8&proxystylesheet=emea_frontend&site=emea_collection (accessed July 2009)
3. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 231(1): 51–58
4. Nilsson B, Bumming P, Meis-Kindblom J, et al. Gastrointestinal stromal tumours: the incidence, prevalence, clinical course and prognostication in preGlivec mesylate era. Cancer, 103: 821–829, 2005
5. Rubin B, Heinrich M, Corless C. Gastrointestinal stromal tumours. Lancet, 368: 1731–1741, 2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current treatment of gastrointestinal stromal tumours;memo - Magazine of European Medical Oncology;2010-06